CervoMed CRVO
NASDAQ CRVO
$2.56 -0.15 (-5.54%)
At close: Aug 20, 2026 · 4:00 PM EDT

CervoMed (CRVO) Net Margin (2011 - 2025)

CervoMed (CRVO) posted Net Margin of 92718.1% for Q4 2025, down 3771.16% sequentially from 2395.1% in Q3 2025, and down 9237996.0% YoY from N/an in Q4 2024.

CervoMed (CRVO) Net Margin (2011 - 2025) Analysis & Trends

CervoMed has reported Net Margin for 6 years, with the latest figure at 92718.1% in Q4 2025.

  • Quarterly Net Margin fell 9237996.0% year-over-year to 92718.1% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 1463.69% (down 124412.0% YoY) and the FY2025 annual result came in at 672.86%, down 48623.0% from the prior year.
  • Net Margin fell to 92718.1% in Q4 2025 per CRVO's latest filing, from 2395.1% in the prior quarter.
  • Over five years, Net Margin peaked at 72.61% in Q2 2023 and troughed at 92718.1% in Q4 2025.
  • A 3-year average of 8083.71% and a median of 208.52% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2024 and 2025: Net Margin plunged 1152 bps in 2024, then sank 9237996 bps in 2025.
  • Over 3 years, Net Margin stood at 105.17% in 2023, then tumbled by 222 bps to 338.14% in 2024, then tumbled by 27320 bps to 92718.1% in 2025.
  • According to Business Quant data, Net Margin over the past three periods registered 92718.1%, 2395.1%, and 377.95% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 30.23%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 31.16%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 12.74%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -3.12%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -16.51%
10 CervoMed 26.12 Mn 26.12 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -92,718.10%
Sep 30, 2025 -2,395.10%
Jun 30, 2025 -377.95%
Mar 31, 2025 -278.42%
Dec 31, 2024 -338.14%
Sep 30, 2024 -244.91%
Jun 30, 2024 -92.36%
Mar 31, 2024 -110.55%
Dec 31, 2023 -105.17%
Sep 30, 2023 -172.13%
Jun 30, 2023 -72.61%
Mar 31, 2023 -99.03%
Jun 30, 2013 3,209.62%
Sep 30, 2012 -1,005.87%
Jun 30, 2012 -1,005.92%
Mar 31, 2012 -260.21%
Dec 31, 2011 -2,580.12%
Sep 30, 2011 -1,654.78%